Current asthma medications, which work by suppressing inflammatory signaling by immune cells or by dilating the airways, can stop working over time. Now, a new study from Boston Children’s Hospital, Brigham and Women’s Hospital, and Harvard Medical School supports a highly innovative approach to controlling asthma; by targeting certain sensory nerve endings in the lungs that help drive allergic inflammation.  The opensource study is published … Continue reading Study successfully targets nerve endings to curb allergic asthma in animal model.